Skip to content

Equity

SHISX

Health Sciences Opportunities Fund

Overview

Loading

Performance

Performance

  • Returns

  YTD 1m 3m 1y 3y 5y 10y
25.25 3.34 14.91 25.25 68.72 75.95 339.23
Benchmark (%) Index: Russell 3000 HealthCare Index.<br /><br /> Index returns are for illustrative purposes only. Index performance returns do not reflect any management fees, transaction costs or expenses. Indexes are unmanaged and one cannot invest directly in an index. Past performance does not guarantee future results.

as of Dec 31, 2019

22.11 3.38 14.93 22.11 58.82 64.49 312.76
Morningstar Category Avg. (%) Health

as of Dec 31, 2019

26.23 3.24 18.64 26.23 55.95 52.11 301.12
Lipper Category Avg. (%) Health/Biotech Funds

as of Dec 31, 2019

26.23 3.24 18.87 26.23 57.56 54.18 318.59
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted. Effective as of May 31, 2018, the performance information for periods prior to the inception date of the share class shows the performance of the Fund’s Investor A Shares. The performance of this share class would be substantially similar to Investor A Shares because this share class and Investor A Shares invest in the same portfolio of securities and performance would only differ to the extent that this share class and Investor A Shares have different expenses. For performance periods prior to May 31, 2018, the performance information for periods prior to the inception date of the share class shows the performance of the Fund’s Investor A Shares, adjusted to reflect the fees and expenses applicable to such share class. See the fund prospectus for more details.

Growth of Hypothetical $10,000 The growth of hypothetical $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted.

Performance chart data not available for display.
View full chart

Distributions

Interactive chart displaying fund performance. Javascript is required.

View full chart

Key Facts

Key Facts

Size of Class (Millions) as of Jan 21, 2020 $43.4 M
Size of Fund (Millions) as of Jan 21, 2020 $8,054.6 M
Share Class launch date Jan 28, 2005
Asset Class Equity
Morningstar Category Health
Lipper Classification Health/Biotech Funds
Benchmark Index Russell 3000 HealthCare Index
CUSIP 091937359
Number of Holdings as of Dec 31, 2019 104
Max Offer Price as of Jan 21, 2020 $66.63
Open to New Investors Yes
Turnover Percent as of Dec 31, 2019 41%

Portfolio Characteristics

Portfolio Characteristics

Average Market Cap (Millions) The average size of the securities the fund invests in. as of Dec 31, 2019 $ 107,161.3 M
R-Squared (3y) as of Dec 31, 2019 96.20
Beta (3y) as of Dec 31, 2019 0.95
Best 3-Month Return Over the Last 3 Years 3 months ending Dec 31, 2019 14.92%
Worst 3-Month Return Over the Last 3 Years 3 months ending Dec 31, 2018 -10.23%

This information must be preceded or accompanied by a current prospectus. For standardized performance, please see the Performance section above.

Ratings

Ratings

Morningstar Rating

4
Overall Morningstar Rating for Health Sciences Opportunities Fund, Service, as of Dec 31, 2019 rated against 135 Health Funds based on risk adjusted total return.

Lipper Leader

 
Overall Lipper Leaders ratings based on an equal-weighted average of percentile ranks for each measure over 3-, 5-, and 10-year periods (if applicable) and do not take into account the effects of sales charges for these categories (Consistent Return, Preservation, Total Return, Expense, and Tax Efficiency) as of Dec 31, 2019 out of 97, 12,253, 97, 30 and 97 Funds, respectively in Lipper's Health/Biotech Funds classification.

Holdings

Holdings

as of Dec 31, 2019
Name Weight (%)
UNITEDHEALTH GROUP INC 8.91
ABBOTT LABORATORIES 4.70
MERCK & CO INC 4.13
THERMO FISHER SCIENTIFIC INC 3.64
MEDTRONIC PLC 3.45
Name Weight (%)
AMGEN INC 3.15
JOHNSON & JOHNSON 3.06
STRYKER CORPORATION 2.76
EDWARDS LIFESCIENCES CORP 2.63
ANTHEM INC 2.61

Exposure Breakdowns

Exposure Breakdowns

as of Dec 31, 2019

% of Market Value

Type Fund Benchmark Net
as of Dec 31, 2019

% of Market Value

Type Fund Benchmark Net
as of Dec 31, 2019

% of Market Value

Type Fund Benchmark Net
as of Dec 31, 2019

% of Market Value

Type Fund Benchmark Net
Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management.

Allocations are subject to change.

Portfolio Managers

Portfolio Managers

Erin Xie
Head of the Health Sciences team

  

Portfolio Manager

Literature

Literature

 

There are many ways to access BlackRock Funds, learn how you can add them to your portfolio